The abstract is read at the publisher; the summary is JClub's.
The 2026 VA/DoD clinical practice guideline strongly recommends motivational interviewing and FDA-approved pharmacotherapies, including varenicline and combination NRT, to increase tobacco abstinence.
- Why it matters: Addressing tobacco use is critical for VA and DoD populations due to high prevalence and associated health risks, yet optimal treatment strategies require updated, evidence-based guidance.
- What they did: A multidisciplinary work group reviewed literature from 2014 to 2024, developing 32 recommendations across 10 topics using GRADE methodology, with input from external experts.
- The result: The guideline emphasizes strong support for motivational interviewing, pharmacotherapies like varenicline, and combination NRT, which may improve quit attempts and abstinence among tobacco users in military and veteran populations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.